A compounded NAD+ protocol, studied to support cellular energy and metabolic function. Prescribed by US-licensed physicians when clinically appropriate.
Founding access, opening soon. No membership fee, no hidden costs.
Join the waitlistReserving early access notifies you when enrollment opens. No charge today. Treatment requires licensed provider review and clinical eligibility.
Compounded NAD+ is not FDA-approved. NAD+ injection therapy is considered experimental. The FDA does not evaluate compounded drugs for safety, effectiveness, or quality. Clinical evidence for NAD+ injection therapy in humans remains limited. A licensed provider must determine if this treatment is clinically appropriate for you. Do not use if pregnant or breastfeeding. Discuss all current medications with your provider before starting, as potential drug interactions have not been systematically studied. Individual results will vary.
Answer questions about your health history, current medications, and goals. Takes under 5 minutes. No video call. No waiting room. 100% HIPAA-secure.
A board-certified clinician reviews your intake and determines if compounded NAD+ is clinically appropriate for you. Not a chatbot. Not an algorithm.
If approved, your prescription is filled by a licensed compounding pharmacy and shipped in discreet packaging within 3 to 5 business days. Free every month.
NAD+ is a coenzyme your cells rely on to convert nutrients into energy. It supports mitochondrial function and DNA repair, and its levels naturally decline with age.
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme derived from vitamin B3 that exists in every cell of the human body. It is essential for converting nutrients into cellular energy (ATP), repairing damaged DNA, and activating sirtuins, a family of proteins involved in aging, inflammation, and stress resistance. NAD+ levels naturally decline with age, which has made it an area of significant research interest.
No. Compounded NAD+ injection is not FDA-approved as a finished drug product. The FDA does not evaluate compounded medications for safety, effectiveness, or quality. NAD+ injection therapy is considered experimental. Most published research on NAD+ supplementation has studied oral precursors (NMN and NR), not injectable NAD+ directly. It is legally prepared by a licensed compounding pharmacy and requires a prescription from a licensed provider.
Oral NAD+ is broken down during digestion. Injectable NAD+ bypasses the digestive system and delivers the coenzyme more directly into the bloodstream or tissue. However, the injectable route also carries different risks, including injection site reactions and, in some patients, flushing or nausea. Most clinical evidence for NAD+ benefits comes from studies of oral precursors (NMN and NR), not injections. Your provider can help determine the most appropriate form for you.
Common side effects include warmth or flushing, mild nausea, headache, and soreness at the injection site. Less common side effects may include fatigue, muscle cramping, dizziness, or temporary changes in heart rate. A 2019 pilot study in elderly adults found that NAD+ infusions were well-tolerated with no serious adverse events. However, large-scale safety data are limited. Your provider will start at a lower dose and adjust based on your response.
NAD+ is a cofactor for hundreds of metabolic reactions. Its primary roles include: powering mitochondrial energy production (the conversion of nutrients to ATP), activating sirtuins and PARPs, enzymes involved in DNA repair and cellular stress response, and supporting the function of immune cells. Animal studies have shown that restoring NAD+ to youthful levels can improve cardiovascular function, muscle endurance, and cognitive performance. Human research is still in early stages and results may not translate directly.
Some patients report improved mental clarity, energy, and sleep quality within 24 to 48 hours of their first session. However, these reports are anecdotal and may be influenced by the placebo effect or the hydration component of treatment. Longer-term changes, if any, would be expected to develop over weeks to months of consistent use. Individual results vary significantly. Clinical evidence for specific timelines is limited, and results are not guaranteed.
NAD+ injections are not recommended for individuals who are pregnant or breastfeeding. Patients taking insulin, oral hypoglycemics, antihypertensives, immunosuppressants, or certain cancer therapies should discuss potential interactions with their provider before starting, as these have not been systematically studied. Your provider will review your full medical history and current medications before prescribing.
Yes. No contracts and no cancellation fees. Cancel anytime through your patient portal or by messaging our support team. Your current month’s shipment will always be sent before any cancellation takes effect.
Free intake. Licensed provider review. Ships if approved.
Reserve your spotFounding access. Fully refundable any time before your first physician consultation.